gross profit bridgeinconsistent2016-03-31
Withheld: gross profit could not be reconciled with the rest of this filer’s statement.
Revenue
$0
Fiscal year ended 2019-12-31Operating income
-$4.55M
Fiscal year ended 2019-12-31Free cash flow
-$5.52M
Fiscal year ended 2019-12-31WINDTREE THERAPEUTICS INC /DE/ (WINT) reported revenue of $0 and net income of -$7.38M for the fiscal year ended 2019-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from WINDTREE THERAPEUTICS INC /DE/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Biological Products, (No Diagnostic Substances).
Income
| Metric | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $158.00K | $40.00K | $304.00K | $229.00K | $1.05M | $204.00K | $102.00K | $17.00K |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | -$4.55M | -$7.19M | -$6.50M | -$6.66M | -$4.85M | -$3.47M | -$3.04M | -$4.84M | -$3.50M | -$4.79M |
| Net income | -$7.38M | -$7.13M | -$6.44M | -$6.54M | -$9.04M | -$3.93M | -$3.05M | -$4.51M | $2.47M | -$5.44M |
| Research & development | $2.14M | $3.79M | $3.41M | $3.34M | $2.37M | $2.20M | $2.88M | $3.12M | $2.42M | $3.06M |
| Weighted-average diluted shares | Unavailable | Unavailable | Unavailable | Unavailable | shares 7.19M | shares 3.77M | shares 3.75M | shares 3.23M | shares 2.54M | Unavailable |
| Pretax income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Income tax expense | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Diluted EPS | Unavailable | Unavailable | Unavailable | Unavailable | $-3.24 | $-1.04 | $-0.81 | $-1.40 | $0.97 | $-10.53 |
| Selling, general & administrative | $2.41M | $3.40M | $3.24M | $3.36M | $2.79M | $1.50M | $1.21M | $1.93M | $1.18M | $1.75M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $22.58M | $4.44M | $6.12M | $2.05M | $11.19M | $640.00K | $638.00K | $1.85M | $1.82M | $1.75M |
| Total assets | $118.98M | $100.63M | $105.24M | $111.63M | $119.40M | $1.94M | $1.98M | $2.97M | $3.35M | $4.66M |
| Current assets | $23.86M | $5.26M | $9.88M | $16.07M | $25.65M | $1.04M | $1.04M | $1.98M | $2.24M | $3.09M |
| Total liabilities | $44.04M | $47.56M | $46.98M | $48.63M | $51.28M | $33.28M | $30.36M | $31.03M | $27.27M | $42.10M |
| Current liabilities | $7.82M | $16.28M | $15.54M | $16.96M | $20.63M | $18.11M | $15.18M | $15.74M | $11.76M | $29.49M |
| Total equity incl. NCI | $74.94M | $53.07M | $58.27M | $63.00M | $68.11M | -$31.33M | -$28.38M | -$28.07M | -$23.92M | -$37.45M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Goodwill | $15.68M | $15.68M | $15.68M | $15.68M | $15.68M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $12.50M |
| Accounts payable | $1.71M | $607.00K | $724.00K | $1.42M | $3.42M | $4.52M | $4.26M | $4.68M | $2.32M | $3.77M |
Cash flow
| Metric | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$5.46M | -$3.82M | -$6.62M | -$8.76M | -$6.19M | -$3.28M | -$3.77M | -$2.55M | -$4.81M | -$3.38M |
| Capital expenditures | $62.00K | -$97.00K | $152.00K | $74.00K | Unavailable | Unavailable | Unavailable | Unavailable | $0 | $0 |
| Investing cash flow | -$62.00K | $2.60M | $10.84M | $425.00K | -$13.74M | $0 | Unavailable | Unavailable | $0 | $0 |
| Financing cash flow | $22.74M | -$346.00K | -$27.00K | -$598.00K | $30.42M | $3.28M | $2.54M | $2.50M | $4.87M | $2.60M |
| Net change in cash | $18.14M | -$1.69M | $4.05M | -$9.13M | $10.58M | $2.00K | -$1.22M | -$46.00K | $63.00K | -$776.00K |
| Stock-based compensation | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $221.00K | $41.00K | $41.00K | $45.00K | $46.00K |
Derived
| Metric | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | -$5.52M | Unavailable | -$6.77M | -$8.83M | Unavailable | Unavailable | Unavailable | Unavailable | -$4.81M | -$3.38M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | Unavailable | Unavailable | -4110.8% | -16642.5% | -1595.7% | -1514.4% | -288.9% | -2372.5% | -3429.4% | -28200.0% |
| FCF margin | Unavailable | Unavailable | -4286.7% | -22082.5% | Unavailable | Unavailable | Unavailable | Unavailable | -4713.7% | -19858.8% |
| SBC / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current ratio | 3.05x | 0.32x | 0.64x | 0.95x | 1.24x | 0.06x | 0.07x | 0.13x | 0.19x | 0.10x |
| Revenue YoY growth | -100.0% | -100.0% | -85.0% | -80.4% | 198.0% | 1247.1% | -8.4% | -6.8% | -88.7% | -98.2% |
| Net margin | Unavailable | Unavailable | Unavailable | Unavailable | -2974.3% | -1714.8% | -290.4% | -2211.8% | 2424.5% | -32017.6% |
| R&D / revenue | Unavailable | Unavailable | 2160.1% | 8355.0% | 778.9% | 959.4% | 273.9% | 1528.4% | 2370.6% | 18011.8% |
| CapEx / revenue | Unavailable | Unavailable | 96.2% | 185.0% | Unavailable | Unavailable | Unavailable | Unavailable | 0.0% | Unavailable |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open WINT in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2025-11-19View SEC filing
10-Q · Filed 2025-08-19View SEC filing
10-Q · Filed 2025-05-15View SEC filing
10-K · Filed 2025-04-15View SEC filing
10-Q · Filed 2024-11-26View SEC filing
10-Q · Filed 2024-08-19View SEC filing
Reconciliation checks needing review
1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.